相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rifampicin markedly decreases the exposure to oral and intravenous tramadol
Tuukka Saarikoski et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction
Nora M. Hagelberg et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Genetically Polymorphic OCT1: Another Piece in the Puzzle of the Variable Pharmacokinetics and Pharmacodynamics of the Opioidergic Drug Tramadol
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Effect of Telithromycin on the Pharmacokinetics and Pharmacodynamics of Oral Oxycodone
Juha Gronlund et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Uptake/Efflux Transport of Tramadol Enantiomers and O-Desmethyl-Tramadol: Focus on P-Glycoprotein
Mouna Kanaan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine
V-V Hynninen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes
U. M. Stamer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception
J. Cory Kalvass et al.
DRUG METABOLISM AND DISPOSITION (2007)
Evaluation of 227 drugs for in vitro inhibition of cytochrome P4502B6
Robert L. Walsky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6
TP Enggaard et al.
ANESTHESIA AND ANALGESIA (2006)
The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions
LM DuBuske
DRUG SAFETY (2005)
Quinidine as a probe for the role of P-glycoprotein in the intestinal absorption and clinical effects of fentanyl
ED Kharasch et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history
E Michna et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Can coadministration of oxycodone and morphine produce analgesic synergy in humans? An experimental cold pain study
M Grach et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients
T Tirkkonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: A multicenter, randomized, double-blind, placebo-controlled study
H Malonne et al.
CLINICAL THERAPEUTICS (2004)
Clinical pharmacology of tramadol
S Grond et al.
CLINICAL PHARMACOKINETICS (2004)
Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine
ED Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial
F Boureau et al.
PAIN (2003)
Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers
S Madani et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Metabolism of the analgesic drug ULTRAM® (tramadol hydrochloride) in humans:: API-MS and MS/MS characterization of metabolites
WN Wu et al.
XENOBIOTICA (2002)
Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs
N Epperson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Affinity, potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor
C Gillen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)